D
dwb71
Seems like the decision of when to operate is changing. Before, a .9 valve area and a 4.5 ascending aorta dilation would be cause for caution, not for surgery. Yet, many "state of the art" institutions, like the Cleveland Clinic, take the position that it is better to operate on a person that once was thought to be too healthy. I am in this grey zone , and frankly find it quite uncomfortable. When the lead instituitions recommend you take action, it is very difficult to go against the grain. Yet, upon reflection, there is little if any downside to their change in philosophy. In fact, it can only be good. Healthier people stand a better chance of survival and therefore the outcomes can only improve. As we know, outcomes are the basis upon which decisions are made with respect to where to receive treatment. With valve replacement, when would it become apparent that delay might have been the better course of action? The answer would most likely be "never", or worst case, when the majority of these "early birds" come around for their "redos", or suffer complications from a regimen of coumandin.
So, I ask, has anyone been in this grey area where the debilitating symptoms are not necessarily prevalent, yet they are getting advice to proceed with surgery? Even bettter, has anyone chosen the "early bird" decision, and would they do it again? This is my first post, and I apologize for the longwindedness
dwb71
AVR and Hemashield in waiting
So, I ask, has anyone been in this grey area where the debilitating symptoms are not necessarily prevalent, yet they are getting advice to proceed with surgery? Even bettter, has anyone chosen the "early bird" decision, and would they do it again? This is my first post, and I apologize for the longwindedness
dwb71
AVR and Hemashield in waiting